Akebia Therapeutics, Inc. (AKBA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.26
Day's range
$1.37

Akebia Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 19.32 M $31.10 M   2.77% 7.30%
VANGUARD GROUP INC 01/29/2026 16.02 M $25.79 M   3.02% 6.05%
STATE STREET CORP 02/13/2026 13.69 M $22.04 M   15.56% 5.17%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 6.28 M $10.11 M   1.49% 2.37%
GOLDMAN SACHS GROUP INC 03/25/2026 4.71 M $7.58 M   166.23% 1.78%
CITADEL ADVISORS LLC 02/17/2026 4.67 M $7.51 M   46.45% 1.76%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 3.59 M $5.78 M   -9.10% 1.36%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 2.99 M $4.82 M   -6.72% 1.13%
CITIGROUP INC 02/13/2026 2.44 M $3.92 M   27.10% 0.92%
NORTHERN TRUST CORP 02/17/2026 2.31 M $3.72 M   -6.97% 0.87%
BANK OF AMERICA CORP /DE/ 02/17/2026 2.26 M $3.63 M   26.22% 0.85%
ACADIAN ASSET MANAGEMENT LLC 02/10/2026 2.20 M $3.54 M   2.41% 0.83%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 2.18 M $3.51 M   0.49% 0.82%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/13/2026 2.00 M $3.22 M   0.00% 0.76%
MILLENNIUM MANAGEMENT LLC 02/17/2026 1.65 M $2.66 M   -42.13% 0.62%
HRT FINANCIAL LP 02/12/2026 1.62 M $2.61 M   6,430.37% 0.61%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 1.57 M $2.53 M   -11.08% 0.59%
FEDERATED HERMES, INC. 02/12/2026 1.29 M $2.08 M   101.94% 0.49%
MORGAN STANLEY 02/13/2026 1.23 M $1.98 M   -71.52% 0.46%
SQUAREPOINT OPS LLC 02/13/2026 1.22 M $1.97 M   57.09% 0.46%
FMR LLC 02/17/2026 1.13 M $1.81 M   23.45% 0.43%
FIRST TRUST ADVISORS LP 02/13/2026 941.66 K $1.52 M   100.00% 0.36%
BARCLAYS PLC 02/13/2026 923.51 K $1.49 M   -21.75% 0.35%
UBS GROUP AG 01/29/2026 871.53 K $1.40 M   -76.10% 0.33%
WELLINGTON MANAGEMENT GROUP LLP 02/17/2026 786.47 K $1.27 M   -9.58% 0.30%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 753.91 K $1.21 M   -26.14% 0.28%
NORDEA INVESTMENT MANAGEMENT AB 01/08/2026 752.11 K $1.21 M   100.00% 0.28%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 730.41 K $1.18 M   -14.92% 0.28%
JANUS HENDERSON GROUP PLC 02/17/2026 704.02 K $1.13 M   510.74% 0.27%
JANE STREET GROUP, LLC 02/12/2026 691.58 K $1.11 M   358.66% 0.26%
INVESCO LTD. 02/19/2026 669.19 K $1.08 M   -72.13% 0.25%
BANK OF NEW YORK MELLON CORP 02/10/2026 666.91 K $1.07 M   -1.82% 0.25%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 657.81 K $1.06 M   -0.71% 0.25%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 647.71 K $1.04 M   31.56% 0.24%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 646.68 K $1.04 M   46.15% 0.24%
NUVEEN, LLC 02/12/2026 592.99 K $954.72 K   -74.23% 0.22%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/14/2026 498.96 K $803.33 K   100.00% 0.19%
RAFFERTY ASSET MANAGEMENT, LLC 02/13/2026 498.62 K $802.78 K   3.48% 0.19%
SWISS NATIONAL BANK 02/12/2026 496.70 K $799.69 K   -2.47% 0.19%
XTX TOPCO LTD 02/17/2026 472.49 K $760.70 K   1,136.84% 0.18%
AMERICAN CENTURY COMPANIES INC 02/13/2026 415.99 K $669.74 K   19.10% 0.16%
TWO SIGMA ADVISERS, LP 02/17/2026 399.95 K $643.92 K   212.83% 0.15%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/17/2026 376.56 K $606.27 K   63.74% 0.14%
PRINCIPAL FINANCIAL GROUP INC 02/02/2026 325.89 K $524.68 K   43.81% 0.12%
CANADA PENSION PLAN INVESTMENT BOARD 02/17/2026 322.90 K $519.87 K   100.00% 0.12%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 319.80 K $514.87 K   -2.19% 0.12%
RHUMBLINE ADVISERS 02/13/2026 317.42 K $511.04 K   -11.50% 0.12%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 02/05/2026 299.77 K $34.09 M   39,976.34% 0.11%
AQUATIC CAPITAL MANAGEMENT LLC 02/17/2026 294.29 K $473.80 K   -41.95% 0.11%
WELLS FARGO & COMPANY/MN 02/13/2026 285.77 K $460.08 K   50.33% 0.11%

Akebia Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 257 institutional investors and hedge funds held shares of Akebia Therapeutics Inc.. The most heavily invested institutionals were:

CITIGROUP INC: 2.85 M

VANGUARD FIDUCIARY TRUST CO: 1.78 M

JANE STREET GROUP, LLC: 1.46 M

DIMENSIONAL FUND ADVISORS LP: 921,923

UBS Group AG: 769,471

Invesco Ltd.: 720,139

44.77% of Akebia Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 141.63 M shares in the last 24 months. This purchase volume represents approximately $191.20 M in transactions.